Komori
Share Issuance and Disposal4586Medrx Co.,Ltd.Pharmaceuticals

Notice Regarding the Monthly Exercise Status of the 35th Series of Stock Acquisition Rights Issued Through a Third-Party Allotment (with Exercise Price Adjustment Terms)

During August 2026, 23,230 of the 35th Series of Stock Acquisition Rights were exercised, resulting in the delivery of 2,323,000 new shares. As of the end of the month, 56,165 rights (5,616,500 shares) remained unexercised.

Worth reading
60In focus
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
2323000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Monthly report on the exercise status of stock acquisition rights with exercise price adjustment provisions issued through a third-party allotment

Who receives how much

Number of shares delivered during the month: 2,323,000 shares (2,323,000 new shares and 0 transferred treasury shares)

グロース・キャピタル株式会社 (the allottee at the time of issuance on 5 June 2026)

The lower thin line represents the existing number of shares to which these shares will be added.

発行済株式総数

Exercise ratio subject to exercise restrictions: 3.91% (2,323,000 delivered shares / 59,365,100 listed shares as of the payment date for the issuance)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
Exercise price during the month in question: ¥61 or ¥62. Details of the adjustment provisions and the adjustment floor: not disclosed
Number of Stock Acquisition Rights
Total issued: 147,820 rights; exercised during the month in question: 23,230 rights; unexercised as of the end of the preceding month: 79,395 rights; unexercised as of the end of the month in question: 56,165 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
5 June 2026: Issuance of the 35th Series of Stock Acquisition Rights with exercise price adjustment provisions, with グロース・キャピタル株式会社 as the allottee (issue price and total amount: not disclosed)
Details of issuance or disposal
ItemDetails
Type of issuance or disposalMonthly report on the exercise status of stock acquisition rights with exercise price adjustment provisions issued through a third-party allotment
Number of shares to be issued or disposed ofNumber of shares delivered during the month: 2,323,000 shares (2,323,000 new shares and 0 transferred treasury shares)
Intended allotteeグロース・キャピタル株式会社 (the allottee at the time of issuance on 5 June 2026)
Dilution RateExercise ratio subject to exercise restrictions: 3.91% (2,323,000 delivered shares / 59,365,100 listed shares as of the payment date for the issuance)
Total number of issued shares66,207,600 shares (as of the end of the month preceding the month in question, including 2 treasury shares) → Not disclosed
Exercise priceExercise price during the month in question: ¥61 or ¥62. Details of the adjustment provisions and the adjustment floor: not disclosed
Number of Stock Acquisition RightsTotal issued: 147,820 rights; exercised during the month in question: 23,230 rights; unexercised as of the end of the preceding month: 79,395 rights; unexercised as of the end of the month in question: 56,165 rights
Procedures under the Corporate Code of ConductThe disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing5 June 2026: Issuance of the 35th Series of Stock Acquisition Rights with exercise price adjustment provisions, with グロース・キャピタル株式会社 as the allottee (issue price and total amount: not disclosed)
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the monthly exercise status of the 35th Series of Stock Acquisition Rights in August 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Monthly Exercise Status of the 35th Series of Stock Acquisition Rights Issued Through a Third-Party Allotment (with Exercise Price Adjustment Terms) | Medrx Co.,Ltd. (4586) timely disclosure | Komori